Effectiveness and Safety of Insulin Glulisine When Initiating Supplementary Prandial Insulin Treatment (SIT) in Insulin-Naïve Patients with Type 2 Diabetes: The Observational IGLU-SIT Study
Crossref DOI link: https://doi.org/10.1007/s13300-021-00998-z
Published Online: 2021-02-05
Published Print: 2021-03
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Pfohl, Martin
Seufert, Jochen
Borck, Anja
Bramlage, Peter
Siegmund, Thorsten
Funding for this research was provided by:
Sanofi-Aventis Deutschland GmbH
Text and Data Mining valid from 2021-02-05
Version of Record valid from 2021-02-05
Article History
Received: 12 November 2020
Accepted: 6 January 2021
First Online: 5 February 2021